Why vendor fragmentation creates risk in CDMOs: challenges in sample management, storage, logistics, and chain-of-custody documentation.
Why vendor fragmentation creates risk in CDMOs: challenges in sample management, storage, logistics, and chain-of-custody documentation.
Why cell and gene therapy programs fail: transition risk, chain-of-identity gaps, and poor sample management. Learn how to build scalable CGT systems.
In regulated biorepositories, compliance requires more than documentation. Discover how governance, traceability, and CAPA systems support audit readiness.
What do auditors actually evaluate in a biorepository? Learn how governance, documentation, and traceability systems determine audit readiness.
Maintaining the integrity and security of valuable biosamples is paramount in the fast-paced world of scientific research. Unfortunately, costly mistakes can occur.
Prevent biological sample loss in GMP biostorage. Learn how redundancy, governance, and monitoring reduce risk in regulated storage.
